Gilead Sciences · 1 day ago
Vice President, Kite Global Supply Chain
Gilead Sciences is dedicated to curing cancer through innovative therapies. The Vice President and Head of Kite Global Supply Chain will lead the global supply chain strategy and execution for clinical and commercial cell therapy products, ensuring compliance and timely delivery across a complex network.
BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Develop, execute, and improve a global supply chain strategy aligned with corporate, financial and customer objectives for clinical and commercial supply
Establish and mature sales and operational planning to enable strategic decision making at ES&OP; partner closely with Commercial and Clinical Operations leaders globally to understand demand scenarios, clinical trial design and enrollment objectives, and risks/opportunities
Own global logistics network, trade compliance, and regional supply chain operations
Integrate corporate systems, data governance, and master data management; evolve digital capabilities to industry benchmarks
Lead technical operations launch readiness, product variation management including global labeling, global distribution, and commercialization planning across geographies
Own BCP across the global supply chain; execute risk assessment/simulations and mitigation strategies aligned with risk frameworks
Develop, manage, and maintain supplier relationships and contractual agreements. Institute KPIs regarding service levels, backorders, inventory levels, forecast accuracy, and production planning against budget and performance goals. Identify and mitigate geopolitical, supplier and operational risk
Owns global supply chain budgets, targets, cost structures. Define KPIs and dashboards to track performance, productivity and risk
Build and develop a high-performing global team; establish training and development roadmaps. Foster close collaboration with key cross-functional partners and create an inclusive culture of excellence
Qualification
Required
Bachelor's in Supply Chain, Business, Science, or Engineering; advanced degree and/or professional supply chain certifications preferred (e.g., APICS)
Executive leadership in high-stakes, patient-centric environment
15–20+ years in biopharma/operations with senior leadership in supply chain; experience across clinical trials supply and commercial E2E planning
Deep expertise in S&OP/ES&OP, capacity planning, logistics/trade compliance, systems integration (SAP, RapidResponse), and data governance
Strong financial acumen and experience managing large budgets
Exemplary track record in strategic vision & execution; lifecycle and launch excellence; risk & BCP leadership; digital and data fluency; and leadership and team development
Strong strategic thinking and ability to implement short- and long-range plans to support overall business strategy. Ability to work hands-on with urgency in a fast-paced, entrepreneurial environment
Proven ability to lead in a matrixed, global environment. Strong executive presence, stakeholder influence and collaboration, clear communication skills, and skilled negotiator
Excellent leadership skills and demonstrated experience building and developing teams. Leading through change and ambiguity, acting as a talent catalyst and identifying and leveraging team members' strengths and coaching through challenges
Outstanding interpersonal skills acting as a trusted advisor and business partner
Company
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
H1B Sponsorship
Gilead Sciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (269)
2024 (241)
2023 (222)
2022 (208)
2021 (235)
2020 (187)
Funding
Current Stage
Public CompanyTotal Funding
$4.41BKey Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B
Leadership Team
Recent News
2026-01-08
2026-01-07
2026-01-06
Company data provided by crunchbase